Relaxin-2 inhibits NHCF-A fibroblasts migration In absence of FBS, RLX2 treatment showed a trend to reduce NHCF-A migration into the wound area.
← all excerpts
Relaxin-2 plasma levels in atrial fibrillation are linked to inflammation and oxidative stress markers.
1
—
—